Michael Lisanti has been an active research scientist for more than three decades with a broad background in cell biology and genetics. He graduated with a degree in Chemistry (Magna Cum Laude) from New York University and obtained his MD-PhD at Cornell University Medical School in Cell Biology and Genetics. From 1992-96, he was a Skeggs Fellow at the Whitehead Institute for Biomedical Research at the Massachusetts Institute of Technology (MIT), followed by several distinguished appointments at the Albert Einstein College of Medicine and the Kimmel Cancer Centre. Michael left the US to continue his research in the UK when he joined the Breastcancer Now Unit in 2012 as Professor of Cancer Biology. He is currently the Chair of Translational Medicine at Salford University and is listed amongst the Top 100 Most-Cited Researchers in Biochemistry and Biology. He has an H-index >154, with over 86,000 citations. Moreover, he has published > 558 papers and is the former Editor-in-Chief of The American Journal of Pathology.